Peptide Science Basics: Evidence-First Education on Peptides and Health

Bottom line Ipamorelin and CJC-1295 are both growth hormone secretagogues that signal the pituitary gland to release more of the body's own growth hormone, but they work through two distinct receptor pathways. The single human study on CJC-1295, published in 2006, showed sustained GH and IGF-1 increases with no serious adverse reactions, but did not evaluate anti-aging, muscle, or fat-loss outcomes. Multiple 2026 clinical reviews agree there is no good-quality, long-term huma

Bottom line GHK-Cu is a naturally occurring copper-binding tripeptide with one of the largest bodies of published research among ‘longevity’ peptides, including decades of work on collagen synthesis, wound healing, and antioxidant activity. Topical GHK-Cu (often listed as ‘copper tripeptide-1’ on ingredient labels) is regulated as a cosmetic ingredient in the U.S. and is widely used in commercial serums and creams without requiring FDA pre-approval. Injectable GHK-Cu is a com

Clinical biohacking is going mainstream in 2026. Here’s what current longevity research actually shows about peptides—and what’s still unproven. Key Takeaways Biohacking is shifting in 2026 from an elite, unregulated subculture toward evidence-based, physician-guided "clinical biohacking"—a convergence of longevity science, functional medicine, and preventive care. Peptides are one of the most discussed tools in this shift, but the evidence base varies enormously by peptide:

Peptides are widely discussed for longevity and athletic performance, but the evidence base is far thinner than most marketing suggests. Most of the striking results—lifespan extension, dramatic muscle gains—come from animal or cell studies, not controlled human trials. This overview separates what current 2026 research actually supports from what remains speculative. Key Takeaways Peptides are short amino acid chains that influence cell signaling, hormone release, and tissue